Skip to main content
. 2018 Aug 27;7(11):e1507668. doi: 10.1080/2162402X.2018.1507668

Figure 7.

Figure 7.

Dex-treatment suppresses expression of myeloid markers in vitro. Monocyte derived macrophages were treated with 0.1, 1, 10 μM Dex for 24 hours, then detached and immunostained for (A) HLA-DR, DP, DQ (MHC-II), (B) CD86, (C) CD80, (D) CD40, (E) HLA-ABC (MHC-I), (F) CCR2 (G) PD-L1, and (H) CD163 and analyzed by flow cytometry. The background mean fluorescence intensity (MFI) of unstained samples was subtracted from experimental samples. Data was then expressed as the fold of treated MFI over untreated (control) MFI. P-values calculated with a one-way ANOVA followed by Dunnett’s multiple comparisons test comparing treated samples to control. Line indicates mean, error bars indicate SEM.